1. Group, F.-N.B.W., 2016. BEST (Biomarkers, EndpointS, and other Tools) Resource.
2. Placebo-like response in absence of treatment in children with autism;Jones;Autism Res.,2017
3. The unfulfilled promise of the N170 as a social biomarker;Key;Biol. Psychiatry Cogn. Neurosci. Neuroimaging,2020
4. Drug development for autism spectrum disorder (ASD): progress, challenges, and future directions;McCracken;Eur. Neuropsychopharmacol.,2021
5. Considerations in biomarker development for neurodevelopmental disorders;McPartland;Curr. Opin. Neurol.,2016